Door-to-needle times for intravenous thrombolytic therapy matter even for ischemic stroke patients who later undergo thrombectomy, a large cohort study finds.
After recurrent thromboembolic phenomena following his second surgical aortic valve replacement, a man in his 50s experiences transient episodes of neurologic symptoms suggestive of TIAs. What is the cause?
As we image more patients with mild strokes early on to look for vascular issues, many are found to have large occlusions. Are they candidates for mechanical thrombectomy? New research aims to find out.
A Cleveland Clinic study presented at the 2018 International Stroke Conference suggests these units may help bypass interhospital transfers for patients requiring thrombectomy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The answer is yes, according to a new national database analysis, but the differences are limited and fairly focused on promptness of reperfusion therapy.
The newly published DEFUSE 3 trial joins the DAWN trial in support of extending the time window for endovascular thrombectomy in selected patients with acute ischemic stroke.
Something’s going right in acute stroke therapy: Medicare data show that one-year mortality fell 18 percent from 2009 to 2013 in tandem with a 60 percent rise in IV tPA use.
Robotic management of a left-sided inferior vena cava (IVC) tumor thrombus is challenging. With meticulous technique, successful outcomes are possible, as this video demonstrates.
Surgery for renal cell carcinoma thrombi that manifest in the renal vein or inferior vena cava is challenging and typically is done as an open procedure. Cleveland Clinic urologic surgeon Georges Pascal-Haber, MD, PhD, demonstrates each step in the first robot-assisted level III renal cancer-associated IVC thrombectomy.